1 |
Yan M, Li X, Gu J, Gao G, Wu Z, Xue P. Blockage of MDM2-mediated p53 ubiquitination by yuanhuacine restrains the carcinogenesis of prostate carcinoma cells by suppressing LncRNA LINC00665. J Biochem Mol Toxicol 2023;37:e23265. [PMID: 36416364 DOI: 10.1002/jbt.23265] [Reference Citation Analysis]
|
2 |
Ghafouri-Fard S, Khoshbakht T, Hussen BM, Baniahmad A, Taheri M, Hajiesmaeili M. A Concise Review on Dysregulation of LINC00665 in Cancers. Cells 2022;11. [PMID: 36429005 DOI: 10.3390/cells11223575] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
3 |
Jin Z, Meng YJ, Xu YS, Wang MM, Chen D, Jiang X, Xiong ZF. Prognostic and clinicopathological values of LINC00665 in cancers: a systematic review and China population-based meta-analysis. Clin Exp Med 2022. [PMID: 36219365 DOI: 10.1007/s10238-022-00912-2] [Reference Citation Analysis]
|
4 |
Zhang C, Xu SN, Li K, Chen JH, Li Q, Liu Y. The Biological and Molecular Function of LINC00665 in Human Cancers. Front Oncol 2022;12:886034. [PMID: 35664776 DOI: 10.3389/fonc.2022.886034] [Reference Citation Analysis]
|
5 |
Zhong C, Xie Z, Shen J, Jia Y, Duan S. LINC00665: An Emerging Biomarker for Cancer Diagnostics and Therapeutics. Cells 2022;11:1540. [DOI: 10.3390/cells11091540] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
6 |
Zhu J, Zhang Y, Chen X, Bian Y, Li J, Wang K. The Emerging Roles of LINC00665 in Human Cancers. Front Cell Dev Biol 2022;10:839177. [DOI: 10.3389/fcell.2022.839177] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
7 |
Li Y, Zhang L, Gong J. Relation among EGFL7, ITGB3, and KLF2 and their clinical implication in multiple myeloma patients: a prospective study. Ir J Med Sci 2021. [PMID: 34635968 DOI: 10.1007/s11845-021-02781-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|